Skip to content

Alpha Cognition ACOG Current ratio

Current ratio at other companies

Biogen logo
BiogenBIIB
3.1×+1.6×
AbbVie logo
AbbVieABBV
0.8×0.0×
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
4.1×-0.8×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.6×+0.7×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
3.1×+0.5×
uniQure logo
uniQureQURE
10.4×-1.6×

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp

Where this comes from

Calculated from Alpha Cognition’s reported figures.

Based on the most recent quarter.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's current ratio?
Alpha Cognition (ACOG) reported current ratio of 12.6× in Q1 2026.
How has Alpha Cognition's current ratio changed year-over-year?
Alpha Cognition's current ratio decreased by 26.3% year-over-year, from 17.1× to 12.6×.
What is the long-term trend for Alpha Cognition's current ratio?
Over 2 years (2023 to 2025), Alpha Cognition's current ratio has grown at a 243.5% compound annual growth rate (CAGR), from 0.7× to 8.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.